Prophylactic Gastrostomy Tubes in Patients Undergoing Intensive Irradiation for Cancer of the Head and Neck

Authors:

Abstract
HEAD AND NECK cancers are commonly diagnosed in advanced stages and are not well controlled with standard radiotherapy.1 In an attempt to improve local tumor control, radiation therapy has been delivered twice a day (accelerated or hyperfractionated)2-4 or concurrently with chemotherapy.5,6 Both of these types of treatment are characterized by increased toxic effects, leading to grade 3 or higher mucositis in the majority of patients as compared with 20% to 30% of patients treated with once-a-day radiotherapy alone.7,8 This mucosal reaction combined with tumor-related anorexia, effects of previous surgery, radiation-related xerostomia, and loss of sense of taste can lead to significant weight loss during radiation treatment.9,10 Severe dehydration and malnutrition may lead to unplanned treatment breaks or hospitalizations, thereby compromising treatment efficacy.11,12

This publication has 23 references indexed in Scilit: